HRT Financial’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,813
Closed -$45K 2245
2024
Q1
$45K Sell
15,813
-28,363
-64% -$87.5K ﹤0.01% 1942
2023
Q4
$155K Buy
+44,176
New +$127K ﹤0.01% 1834
2022
Q2
Sell
-260,846
Closed -$2.21M 2957
2022
Q1
$2.21M Buy
260,846
+176,808
+210% +$1.24M 0.02% 601
2021
Q4
$742K Buy
+84,038
New +$799K ﹤0.01% 1418
2021
Q3
Sell
-87,056
Closed -$914K 3289
2021
Q2
$914K Buy
87,056
+37,361
+75% +$369K 0.01% 1196
2021
Q1
$511K Sell
49,695
-40,258
-45% -$560K 0.01% 1759
2020
Q4
$996K Buy
89,953
+30,940
+52% +$316K 0.02% 678
2020
Q3
$593K Buy
+59,013
New +$596K 0.02% 800

Other funds holding SRTA

HRT Financial's SRTA Position: Q2 2024 in Review

HRT Financial sold out of Strata Critical Medical Inc (SRTA) in Q2 2024, closing a stake of 15,813 shares — an estimated $45K sold.

HRT Financial first reported a position in SRTA in Q3 2020 and held it in 8 quarters. The position peaked at $2.21M in Q1 2022. 117 funds tracked by Wall St. Rank hold SRTA as of Q2 2024.

  • HRT Financial reported no remaining Strata Critical Medical Inc position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 15,813 Strata Critical Medical Inc shares in Q2 2024, an estimated $45K.
  • HRT Financial first reported a position in Strata Critical Medical Inc in Q3 2020 and held it in 8 quarters.
  • HRT Financial's Strata Critical Medical Inc position peaked at $2.21M in Q1 2022.
  • 117 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.